Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women—but until now, they have been underrepresented in genomic studies aimed at ...

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, ...

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation, ...

Researchers have tested a new cancer drug in pet cats with head and neck squamous cell carcinoma – a disease notoriously hard to treat. The trial showed the therapy controlled cancer in 35 percent of ...

Statins, drugs for high cholesterol, show promise in slowing colorectal cancer growth. Researchers at Shiv Nadar University and IISER Pune found statins target key pathways in cancer cells. The study ...

Researchers have discovered that statins, drugs typically used for high cholesterol, could potentially slow the growth of colorectal cancer cells.

Oregon Health and Science University (USA) researcher Prof Sanjay Malhotra participates in ‘international SPARC cancer ...

U.S. Gene Editing Market to Expand from USD 1.95 Billion in 2024 to USD 4.82 Billion by 2032, Driven by Growing Therapeutic Applications, Federal Research Funding, and Biotech Investments.Austin, Sept ...

In conclusion, this comprehensive pan-cancer bioinformatics analysis on the role of the CISD1 gene in different aspects of tumorigenesis reveals that CISD1 could serve as a “ reliable and ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Researchers have launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for advanced transcriptomic data analysis. Designed within the R statistical environment, this ...